Big Pharma NewsWatch
-
June 26, 2023
A Son Died, His Parents Tried to Sue. How U.S. Courts Protect Big Pharma + More
-
June 23, 2023
GSK Soothes Investors by Settling First Zantac Cancer Lawsuit Due for U.S. Trial + More
-
June 22, 2023
CDC Advisors Back RSV Vaccine for Older Adults, With Caveats + More
-
June 20, 2023
The Dark Side of Medications: These Drugs Do More Harm Than Good + More
-
June 14, 2023
Super-Engineered Vaccines Created to Help End Polio + More
-
June 08, 2023
Moderna to Test Mpox Vaccine in Humans This Summer + More
-
June 07, 2023
Antibody for Infant RSV Prevention to Face FDA Panel + More
-
June 05, 2023
Most U.S. Adults Are Declining COVID Boosters as CDC Warns of Health Risks: ‘Relatively Little Protection’ + More
-
June 01, 2023
FDA Approves Pfizer RSV Vaccine for Older Adults + More
-
May 31, 2023
Sackler Family, the Maker of OxyContin, Will Be Shielded From Lawsuits as Part of $6 Billion Settlement + More
-
May 26, 2023
Ozempic in Teens Is a Mess + More
-
May 25, 2023
Abbott, Baby Formula Makers Face FTC Probe for Potential Collusion + More
-
May 23, 2023
Parents’ Mistrust of HPV Vaccine May Be Growing + More
-
May 22, 2023
If Bird Flu Starts to Spread Among People, Existing Vaccines May Be Inadequate, Experts Say + More
-
May 19, 2023
CDC Reports Another Death Linked to Recalled Eyedrops + More
-
May 18, 2023
FDA Advisers to Consider RSV Vaccine to Protect Newborns + More
-
May 17, 2023
Guess How Much Big Pharma Paid in U.S. Taxes on $110 Billion of Profit in 2022 + More
-
May 16, 2023
Pfizer RSV Vaccine for Infants Has ‘Generally Favorable’ Safety Data, FDA Staff Say + More
-
May 15, 2023
J&J COVID Vaccine No Longer Available in the U.S. + More
-
May 11, 2023
Maternal RSV Vaccine: Further Analysis Is Urged on Preterm Births + More
-
May 10, 2023
AI Drug Discovery Is a $50 Billion Opportunity for Big Pharma + More
-
May 09, 2023
Novavax Forecasts Higher-Than-Expected Revenue; Shares Surge + More
-
May 03, 2023
FDA Approves First Vaccine for RSV, a Moment Six Decades in the Making + More
-
May 02, 2023
Pfizer Earnings and Revenue Top Expectations Despite COVID Vaccine Sales Decline + More
-
April 28, 2023
U.S. FDA Approves Pfizer’s Next-Generation Pneumococcal Vaccine for Infants as Young as 6 Weeks + More
-
April 27, 2023
Gearing Up for Key Approvals, GSK Projects ‘Shingrix-Like’ Sales for Its RSV Vaccine + More
-
April 25, 2023
WHO, Gates Foundation Seek to Reverse Falling Childhood Vaccination Rates + More
-
April 21, 2023
Youth Suicide Attempts by Poisoning Rose 30% in U.S. During COVID + More
-
April 18, 2023
FDA Authorizes Additional Omicron COVID Booster for Seniors and People With Weak Immune Systems + More
-
April 12, 2023
Many Younger U.S. Women Say Flu, COVID Vaccines Not Safe in Pregnancy + More